Main Street Research’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$421K Sell
6,942
-7,678
-53% -$448K 0.02% 92
2025
Q4
$789K Sell
14,620
-95
-0.6% -$4.57K 0.05% 62
2025
Q3
$664K Buy
14,715
+108
+0.7% +$5.04K 0.04% 68
2025
Q2
$676K Sell
14,607
-1,643
-10% -$80.7K 0.04% 63
2025
Q1
$991K Buy
16,250
+993
+7% +$57.9K 0.06% 57
2024
Q4
$863K Buy
15,257
+25
+0.2% +$1.4K 0.05% 60
2024
Q3
$788K Sell
15,232
-2,400
-14% -$113K 0.05% 63
2024
Q2
$732K Sell
17,632
-986
-5% -$44.1K 0.05% 58
2024
Q1
$1.01M Sell
18,618
-2,379
-11% -$121K 0.07% 54
2023
Q4
$1.08M Hold
20,997
0.09% 53
2023
Q3
$1.22M Hold
20,997
0.13% 53
2023
Q2
$1.34M Hold
20,997
0.21% 42
2023
Q1
$1.46M Sell
20,997
-1,351
-6% -$95.3K 0.29% 35
2022
Q4
$1.61M Buy
22,348
+61
+0.3% +$4.6K 0.39% 30
2022
Q3
$1.58M Buy
22,287
+160
+0.7% +$11.6K 0.35% 28
2022
Q2
$1.7M Buy
22,127
+100
+0.5% +$7.62K 0.45% 25
2022
Q1
$1.61M Sell
22,027
-318
-1% -$21.4K 0.15% 44
2021
Q4
$1.39M Sell
22,345
-1,544
-6% -$90.6K 0.11% 53
2021
Q3
$1.41M Sell
23,889
-280
-1% -$18.4K 0.12% 54
2021
Q2
$1.61M Sell
24,169
-17
-0.1% -$1.11K 0.13% 58
2021
Q1
$1.53M Sell
24,186
-891
-4% -$55.4K 0.14% 58
2020
Q4
$1.56M Sell
25,077
-1,102
-4% -$67.8K 0.17% 53
2020
Q3
$1.58M Sell
26,179
-1,666
-6% -$100K 0.2% 47
2020
Q2
$1.64M Sell
27,845
-860
-3% -$51.4K 0.26% 40
2020
Q1
$1.6M Sell
28,705
-122
-0.4% -$7.46K 0.39% 32
2019
Q4
$1.85M Buy
28,827
+1,509
+6% +$86.4K 0.29% 41
2019
Q3
$1.39M Sell
27,318
-600
-2% -$28.2K 0.26% 43
2019
Q2
$1.27M Sell
27,918
-650
-2% -$30.3K 0.28% 37
2019
Q1
$1.36M Hold
28,568
0.43% 30
2018
Q4
$1.49M Hold
28,568
0.58% 26
2018
Q3
$1.77M Sell
28,568
-200
-0.7% -$11.9K 0.25% 46
2018
Q2
$1.59M Sell
28,768
-2,363
-8% -$128K 0.25% 47
2018
Q1
$1.97M Buy
31,131
+1,250
+4% +$80.4K 0.31% 45
2017
Q4
$1.83M Sell
29,881
-772
-3% -$48.3K 0.28% 47
2017
Q3
$1.95M Sell
30,653
-3,300
-10% -$193K 0.32% 51
2017
Q2
$1.89M Sell
33,953
-700
-2% -$38.1K 0.31% 54
2017
Q1
$1.88M Sell
34,653
-200
-0.6% -$11K 0.33% 57
2016
Q4
$2.04M Sell
34,853
-68,305
-66% -$3.73M 0.4% 56
2016
Q3
$5.56M Sell
103,158
-73,703
-42% -$4.73M 1.09% 45
2016
Q2
$13M Buy
176,861
+7,994
+5% +$565K 2.69% 5
2016
Q1
$10.8M Buy
168,867
+6,957
+4% +$439K 2.78% 7
2015
Q4
$11.1M Buy
161,910
+6,832
+4% +$451K 2.38% 5
2015
Q3
$10.2M Buy
155,078
+4,696
+3% +$298K 2.4% 7
2015
Q2
$10M Buy
150,382
+7,050
+5% +$465K 2.05% 6
2015
Q1
$9.24M Buy
143,332
+835
+0.6% +$52.3K 1.99% 8
2014
Q4
$8.41M Buy
142,497
+4,564
+3% +$257K 1.8% 12
2014
Q3
$7.06M Sell
137,933
-1,746
-1% -$87.2K 1.57% 20
2014
Q2
$6.78M Sell
139,679
-1,350
-1% -$66.5K 1.6% 21
2014
Q1
$7.33M Buy
141,029
+4,118
+3% +$219K 1.78% 10
2013
Q4
$7.28M Sell
136,911
-959
-0.7% -$48.9K 1.82% 8
2013
Q3
$6.38M Sell
137,870
-2,645
-2% -$116K 1.72% 10
2013
Q2
$6.28M Buy
+140,515
New +$6.1M 1.9% 9

Other funds holding BMY

Main Street Research's BMY Position: Q1 2026 in Review

Main Street Research reduced its Bristol-Myers Squibb (BMY) stake by 53% in Q1 2026, selling an estimated $448K and leaving 6,942 shares worth $421K. The position accounts for 0.02% of the portfolio, ranked #92.

Main Street Research first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $13M in Q2 2016. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Main Street Research held 6,942 shares of Bristol-Myers Squibb worth $421K as of Q1 2026.
  • Main Street Research sold 7,678 Bristol-Myers Squibb shares in Q1 2026, an estimated $448K.
  • Bristol-Myers Squibb made up 0.02% of Main Street Research's portfolio in Q1 2026, its #92 holding.
  • Main Street Research first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Main Street Research's Bristol-Myers Squibb position peaked at $13M in Q2 2016.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Main Street Research's 13F filing for Q1 2026, filed 30 Apr 2026.